Citigroup’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07K | Sell |
2,303
-12,841
| -85% | -$28.3K | ﹤0.01% | 4534 |
|
|
2025
Q1 | $32.7K | Sell |
15,144
-1,705
| -10% | -$3.68K | ﹤0.01% | 4222 |
|
|
2024
Q4 | $71.3K | Buy |
16,849
+1,383
| +9% | +$5.85K | ﹤0.01% | 4128 |
|
|
2024
Q3 | $177K | Buy |
15,466
+13,513
| +692% | +$155K | ﹤0.01% | 3658 |
|
|
2024
Q2 | $20.9K | Sell |
1,953
-31,889
| -94% | -$341K | ﹤0.01% | 4249 |
|
|
2024
Q1 | $519K | Buy |
+33,842
| New | +$519K | ﹤0.01% | 2831 |
|